Radius Health. Inc.


Radius is a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing innovative endocrine therapeutics in the areas of osteoporosis and oncology. Radius' lead product, TYMLOS (abaloparatide) injection, was approved by the U.S. Food and Drug Administration for the treatment of postmenopausal women with osteoporosis at high risk for fracture. For more information, please visit www.radiuspharm.com, and follow us on Twitter and LinkedIn.

550 E Swedesford Rd
Wayne, Pennsylvania 19087
(484) 459-8293